NYU Langone Health

Connect with us:

Latest from NYU Langone Health

Natalizumab Demonstrates Some Impact on Drug-Resistant Epilepsy

September 27, 2021

Despite not achieving statistical significance, there was greater relative reduction in seizure frequency over placebo in those with a structural etiology for focal epilepsy than those without, laying the foundation for future research.